HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Health)

Set Alert for Business {Health}

Deals

Set Alert for Deals {Health}

Latest From Health & Deals

Stada Strikes Deal To Expand Middle East And Africa OTC Portfolio

A deal between Stada Arzneimittel and Adcan Pharma will see the former exclusively market and commercialize in the UAE a portfolio of 15 consumer healthcare products produced and supplied by the latter.

Middle East and Africa United Arab Emirates

US Wellness Market Movers: Doctor’s Best, Society Brands, CharmHealth

Doctor's Best acquires Viactiv calcium and magnesium brand from Guardion; VitaliyNow is Society Brands’ third 2024 acquisition; and VitaminLab formulation services on CharmHealth.

Dietary Supplements Deals

Spain's Uriach Expands In Europe With Pascoe And Ineldéa

Consumer health manufacturer Uriach has agreed to acquire Germany's Pascoe Naturmedizin and through a separate transaction France's Laboratoires Ineldéa, following investment by private-equity firm ICG.

Europe France
See All

Strategy

Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

Stada Strikes Deal To Expand Middle East And Africa OTC Portfolio

A deal between Stada Arzneimittel and Adcan Pharma will see the former exclusively market and commercialize in the UAE a portfolio of 15 consumer healthcare products produced and supplied by the latter.

Middle East and Africa United Arab Emirates

Over The Counter: How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz

Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and head of R&D, North America and Therapeutics, Rachel Koontz.

Europe International

Talc Litigation Attorneys Allege ‘Bad Faith Filings,’ ‘Fraudulent Activities’ By J&J In Bankruptcy

Attorneys for some plaintiffs alleging harm from talc products J&J marketed ask a court to order the firm, along with a subsidiary holding company it created in 2021 to manage its talc liabilities and immediately placed in bankruptcy, to provide emails and other communications among in-house counsel and compel their testimony.

Cosmetics OTC Drugs
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Alliance Pharma Books £46m Impairment Charge Related To US Menopause Supplement

Alliance Pharma has been hit by a non-cash impairment charge of £46.4m related to its Amberen dietary supplement reflecting the brand's struggles in the US e-commerce market.

Sales & Earnings Dietary Supplements

Marketplace Shows Consumers Bouncing Off Gummy Form Vitamins, Church & Dwight Sees

More than a decade after acquiring vitafusion and L’il Critter gummy vitamin brands and touting gummy as a key growth driver in the VMS space, C&D’s seeing different market trends.

Dietary Supplements Retail

Clear Eyes Production Problems Prestige Consumer Didn’t See Coming Leave Supply On Shelves ‘Spotty’

“Clear Eyes is a perfect example where we're dual-sourced and two facilities don't usually go down at the same time. This was just a quite an anomaly,” says CFO Christine Sacco, noting PCH works with more than 100 contract manufacturers.

OTC Drugs Supply Chain
See All

Litigation

Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

Deference No More: More Challenges Against US FDA After Supreme Court Tosses Chevron Doctrine?

The Supreme Court’s 6-3 ruling is expected to have a minimal impact on drug approvals and other scientific determinations, but matters steeped in the interpretation of regulation and statute, such as marketing exclusivity, could face a heightened risk of challenge, legal experts say.

Legal Issues FDA

Supreme Court Mifepristone Decision Sets High Bar For FDA Suits, But Risks To Agency Authority Linger

The unanimous decision that the Alliance for Hippocratic Medicine lacks standing to challenge the FDA’s relaxation of the abortion pill REMS leaves unclear whether the court would have deferred to the agency’s expertise on the merits. 

Women's Health Litigation

NAD Oddball: Thermometer Case Administratively Closed As Advertiser Takes Matter To Federal Court

Exergen seeks a declaration from Massachusetts federal court that claims challenged by Baxter in the National Advertising Division forum regarding the accuracy of its thermometers do not constitute false or misleading advertising, if they are even advertising at all.

Advertising, Marketing & Sales Legal Issues
See All
UsernamePublicRestriction

Register